A 28-year-old with severe atopic dermatitis refractory to optimized topical therapy seeks systemic options. Which aligns with 2023-2024 US guidance?...

Question

A 28-year-old with severe atopic dermatitis refractory to optimized topical therapy seeks systemic options. Which aligns with 2023-2024 US guidance?

Accepted Answer

Initiate a biologic (e.g., dupilumab) as a systemic option

Answer

Systemic corticosteroids long-term are preferred

Answer

Antibiotics chronically for skin flora control

Answer

No systemic therapy is recommended

Answer

UV phototherapy is contraindicated

us-abfm MCQ (SBA): Atopic Dermatitis (Systemic Tx)